Optimizing Lymphatic Pumping for Influenza Vaccine Responses in Vulnerable Populations
Lake Erie College of Osteopathic Medicine · NCT07786467
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- September 2026
- Record last updated
- September 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The investigators are studying if a specific osteopathic manipulative treatment protocol can improve the immune response (antibody titers) to seasonal influenza vaccination in vulnerable populations, including patients with advanced age and/or adiposity.
Being studied: Osteopathic Manipulation; Osteopathic manipulation; Sham
Conditions: No Disease or Condition is Being Directly Studied; The Focus of the Study in Healthy Volunteers
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Willing to receive OMT
- Willing to receive influenza vaccine
- Older than 18 years of age
Exclusion Criteria
- Younger than 18 years of age
- Pregnancy or lactation
- Unwilling to receive the influenza vaccine
- Unwilling to receive OMT
- Open wounds
- Bone fractures
- Moderate to severe osteoporosis
- Severe COPD
- Current/active infections
- Mononucleosis infection within past 6 months
- Liver cirrhosis
- Cancer or metastatic disease
- History of DVT, PE, or blood clotting disorder
- Individuals taking blood thinning medications, except aspirin
- Having a pacemaker or other thoracic medical devices
Recruiting US locations
Plaza 38 Medical Offices
Erie, PA 16509
Site contact: Jacob Cukierski, DO · 814-860-8414 · jcukierski@lecom.edu
Study contacts (from the official record)
- David Duriancik, Ph.D. · 814-860-5139 · dduriancik@lecom.edu
- Irv Freeman, J.D., Ph.D. · 724-552-2870 · ifreeman1@lecom.edu
Similar studies in Pennsylvania
All vaccine studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults
National Institute of Allergy and Infectious Diseases (NIAID)
- Location
- Pittsburgh, PA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV
National Institute of Allergy and Infectious Diseases (NIAID)
- Location
- Philadelphia, PA + 6 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 3
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Pfizer
- Location
- Bellevue, PA + 101 other US sites
- Eligibility basics
- Ages 1 mo–7 mo